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Using an improved 3’ RACE (PCR) amplification system containing oligonucleotide primer with an inosine at ambiguous codon posltions and 
mverse PCR to amplify the 5’ ends, we have isolated and characterized cDNA clones which encode clonin, a protochordean homologue of the 
mammahan hormones. cholecystokmin (CCK) and gastrin The full-length cloned cDNA of 510 bp encoded a 128 amino acid preproclonm. Reverse 
transcrlptlon_PCR and subsequent cDNA clonmg revealed that clonm mRNA 1s expressed m both the neuronal ganglion and the gut of the 
protochordate C’lona mtestrnalis. The primary structure of procionm resembles that of proCCK more than that of progastrin. Sequence-specific 
immunochemlcal analysis showed that the cionin gene 1s expressed also at peptide level in both the gut and the neural ganglion. The neuronal 
processmg of proclomn 1s. however. more complete both with respect to carboxyamldatlon and tyrosine 0-sulfation. Hence, the tissue-specific 
expression of the clonm gene m C~orza mteJtmahs resembles that of the CCK gene m mammals. 
cDNA cloning, Cholecqstokmm: Ciorlu ~nrestrrulu; Cionin. Gastrm, Prohormone processmg 
1. INTRODUCTION 
Cholecystokinin (CCK) and gastrin are important 
mammalian brain and gut hormones (for review, see 
[l]). CCK and gastrin have the same C-terminal active 
site, Gly-Trp-Met-Asp-Phe-NH,. The binding to either 
CCK or gastrin receptors is determined by the exact 
position of an adjacent tyrosyl residue. Thus. tyrosine 
in position six (as counted from the C-terminus) renders 
the peptide gastrin-like, whereas tyrosine in position 
seven is characteristic for CCK. The active site homol- 
ogy indicates that CCK and gastrin may have a com- 
mon ancestor [2]. 
In evolution, protochordates occupy a crucial posi- 
tion immediately prior to vertebrates. Consequently, in 
a search for a common ancestor we recently isolated 
from the neural ganglion of the protochordate, Ciorza 
intestinalis, a disulfated octapeptide amide named 
cionin [3]. Cionin has sulfated tyrosyl residues in both 
positions six and seven in addition to a pentapeptide 
amide identical to the common C-terminus of CCK and 
gastrin. Thus, cionin is structurally a hybrid of CCK 
and gastrin, and therefore related to the putative com- 
mon ancestor. 
The unique structure of cionin raises a number of 
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questions. Does procionin resemble proCCK more than 
progastrin? Is procionin a polyprotein like the precur- 
sors of the related frogskin peptide, caerulein [4]? Is the 
structure of procionin N-terminal to the cionin octapep- 
tide sequence sufficiently acidic to be in accordance with 
the suggested consensus site for tyrosyl sulfation [5]? Is 
cionin ~ like CCK and gastrin - also expressed in the 
gastrointestinal tract? In order to answer these ques- 
tions, we have now cloned the cionin cDNA and exam- 
ined the cionin gene expression in Ciona intestinalis. The 
obvious question of the effect of cionin in mammals was 
recently answered in studies which showed an activity 
of cionin similar to that of CCK [6]. 
2. MATERIALS AND METHODS 
2.1. Ampll$cation and clonmg of the ~lomn 3’ end 
3’ RACE (rapld amplification of cDNA ends) was accomplished 
according to the procedure of Frohman et al. [7]. Using a Gene Amp 
RNA-PCR kit (Perkin Elmer Cetus. Norwalk, CT, US). oligo-d(T),,- 
primed cDNA synthesis (single stranded) was performed with 1 pg of 
poly(A)’ RNA from the Cro?zu gut and neuronal ganglion, respec- 
tively. Single stranded cDNA was amplified with AmphTaq DNA 
polymerase (Perkm Elmer Cetus) and a deoxymosine-containing sense 
oligonucleotlde (#l, Table I) and oligo-d(T),j Not1 primer/adaptor, 
using a DNA Thermal Reactor (Hybaid Inc., Middlesex. UK). 33 
cycles of amplification were carried out as follows: 95”C, 3 min; 31°C. 
3 min; 7O”C, 3 min: (3 cycles): 93°C. 3 min; 42°C. 3 min. 70°C. 3 min; 
(30 cycles). followed by a 15-min final extension at 70°C The PCR 
product was cleaved with Not1 and EcoRI and cloned mto the tran- 
scriptlon vector pGEM-11 zf(-) (Promega Inc . Madison, WI, US). 
This construct was used to transform competent DH5a cells. Plastmd 
preparations [8] and subsequent sequence analysis ylelded three posl- 
tive clones. 
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Positions and DNA sequences of the prtmers used m this study to amplify Clonin DNA by PCR techniques as described in section 2 
Name Primer no. Sequence, Y-to-3 orientation Start position in cDNA Restriction enzyme site 
Cionin26mer #l 
sense 
Cionin-26mer #2 
antisense 
NTR-3’ antisense #4 
NTR-3’ sense #7 
Cionin-5’ sense #9 
GAATTCAAITAITAIGGITGGATGGAITTIGG 314 4 EcoRI 
CCIAAITCCATCCAICCITAITAITT 399 t _ 
Cionin-5’ sense 
oligo-d(T) Not 
GGATCCAACGTTACATTTTACGATGAATATG 463 t BumHI 
GAATTCGTTTTCTTCGCTCAA 461 4 EcoRI 
GTCGACCAATGAGCATGGGAAGCAATATCGTTA 42 4 SalI 
#lO GTCGACTATCATTGTTATAGTAACGTTAAATGT 19 4 SalI 
Commercially available poly(A) tail Nor1 
2.2. Amphjkatron and clonrng of the cionin 5’ end by inverse PCR 
1 fig of poly(A)’ RNA was used for ohgo-d(T)/Xba-primed cDNA 
synthesis using Promega’s cDNA kit. Inverse PCR was carried out as 
described [9]. using cionin specific primers #4 and #7 (Table I). 32 
cycles of amplification were performed: 94°C. I min; 37°C. 1 mm; 
72°C. 2 min (2 cycles): 92°C. 1 min; 42”C, 1 min, 72”C, 2 mm; (30 
cycles), followed by a final 15 min extension at 72°C. The PCR- 
amplified product of -650 bp was digested with EcoRI and BamHI 
restriction enzymes and cloned into plasmtd vector pGEM-3 
(Promega Inc.). Recombinant plasmids containing appropriate inserts 
were sequenced using SP-6. T7, and ctonin-26 ohgomer sequencing 
primers and a commercially available DNA sequencing Kit (Se- 
quenase, Version 2.0. US Biochemical Corp., Cleveland. OH, US). 
2.3. Nortliern blot unalw~ 
Total RNA from the gastrointestinal tract and neuronal ganglion 
was extracted as earlier described [IO]. Electrophoretic separation of 
total RNA on a 1.2% agarose-0.7% formaldehyde gel was followed 
by capillary transfer onto Hybond-N membrane (Amersham, 
Birkerad. Denmark) in 25 mM sodium phosphate buffer, pH 6.4. 
Filters were fixed by UV-illumination (Stratagene. UV box). Prior to 
transfer, RNA preparations were routinely checked for degradation 
by ethidium bromide staining of the agarose gel. Hybridization analy- 
sis was performed using the cionin PC-III, cDNA template, obtained 
by 3’ RACE clonmg of poly(A)’ RNA from the gastrointestinal tract 
under standard riboprobe conditions, as described [1 11. 
2.4. Immunochemical analysis 
The glycme-extended intermediate precursors of cionin were meas- 
ured with antiserum #3208 using “51-labeled glycine-extended gastrin- 
13 as tracer and sulfated glycine-extended CCK-8 as standard [12]. 
Carboxyamtdated cionin peptides were measured with antiserum 
#2609. which cross-reacts fully wtth sulphated and non-sulphated 
CCK peptides. as well as with carboxyamidated gastrin peptides [13]. 
Tyrosine-sulfated and carboxyamtdated CCK peptides were also 
measured using antiserum G160, which binds only sulfated cionin 
peptides [14]. 
2.5. Enzymatlcul cleavage 
In order to measure peptides extended beyond glycine. i.e. pro- 
ciomn. extracts and chromatographic fractions were cleaved with 
trypsin (1 mg trypsimml sodiumphosphate solution, pH 8.2) and car- 
boxypepttdase B before measurements using antiserum #3208 as ear- 
lier described ([12], see also Fig. 4). 
2.6 Chromatography 
Extracts of 1 ml were applied to calibrated Sephadex GSO superfine 
columns (10 x 1.000 mm) and eluted at 4°C with 0.125 M NH,HCO, 
at a flow rate of 4 ml/h. Fractions of 1.0 ml were collected. The void 
volume of the columns were indicated by ‘?-albumin and the total 
volume by “NaCI. The columns were further calibrated with synthettc 
cionm. glycine-extended CCK-8 (sulfated), and carboxyamidated 
CCK-33. Moreover. the columns were calibrated with neutral and acid 
extracts of porcine small intestine and cerebral cortex. 
3. RESULTS AND DISCUSSION 
3.1. ArnpliJicution and cloning of the cionin 3’ erld by the 
inosine primer-PCR cloning (IPPC) technique 
Synthetic deoxyribo-oligonucleotides, the sequences 
of which were deduced from those of known amino acid 
sequences, have been used as powerful tools in cloning 
cDNAs. Most often mixed oligonucleotide pools, con- 
sisting of oligonucleotides with sequences degenerate at 
the ambiguous codon positions, have been used. How- 
ever, Ohtsuka et al. [15] described an alternative ap- 
proach using oligonucleotides with deoxyinosine in- 
Cionin Asn - Tyr - Tyr - Gly - Trp - Met - Asp - Phe * NH, 
Cionin, 5’- AAI - TAI - TAI - GGI - TGG - ATG - GAI - TTI - GG - 3’ 
sense primer 
1 1 + I t + 
3’-RACE 5’ - AAG TAG TAG GGG TGG ATG GAG TTG GGT- 3’ 
5’-RACE --T _-T __C _ _T ___ ___ -_T _-T ___ 
I 
Fig. 1. The nucleotide sequence of Cionin-26 mer, containing deoxyinosine residues at ambiguous codon positions. The cionin ammo acid sequence 
was as prevoiusly described [3]. Arrows indicate insertion of G residues at inosine positions (3’ RACE). T or C indicate the correct nucleotides 
at ambiguous codon positions, obtained by Inverse PCR cloning. 
61 
Volume 33 1. number 1.2 FEBS LETTERS September 1993 
5' GTCGACACGAAGCGTCGGT GATTGGTTTTTCTGGAAAATTTCAATGAGC 49 
1 MetGlySerAsnIleValIleTyrPheSer IleIleValIleValThrLeuAsnValAsn 
ATGGGAAGCAATATCGTTATTTATTTTTCT ATCATTGTTATAGTAACGTTAAATGTGAAT 109 
21 GlyValProAlaSerAspLeuPheLysSer ValSerGlnTyrHisIleProArgSerLys 
GGCGTTCCAGCATCTGATTTGTTCAAGTCC GTGTCGCAATACCACATTCCCCGAAGCAAA 169 
41 ValIleAsnLysGluThrValThrLysPro LeuGlnPheGlnArgAlaIleCysArgLeu 
GTCATCAATAAAGAGACCGTAACAAAACCG CTTCAGTTTCAAAGAGCTATTTGCCGGCTC 229 
61 LeuGlnLysLeuGlyGluGluThrPheAla ArgLeuSerGlnSerGluLeuGluAlaLys 
TTGCAAAAACTTGGGGAGGAAACATTTGCT CGGTTGTCTCAATCGGAACTTGAAGCAAAA 289 
81 GlnLeuAspLeuIleLysThrCysTyrGln AlaAsnSerPheGlyAspAsnGluAsnGln 
CAGCTGGATTTAATCAAAACTTGCTACCAG GCAAACAGCTTTGGGGATAATGAGAATCAG 349 
101 GlyHisMetGlnArgMetAspArgAsnTyr TyrGlyTrpMetAspPheGlyLysArgAla 
GGTCATATGCAAAGAATGGATCGAAACTAT TACGGCTGGATGGATTTTGGTAAAAGAGCA 409 
121 IleGluAspValAspTyrGluTyrEnd 
ATCGAAGATGTTGATTATGAATATTAAGAA CATATTCATCGTAILAATGAACGTTTTCTTC 469 
GCTCAATGCTTATATTGTTTAAATAAATTT CGTGCAACGACA 3' 529 
Fig. 2. Nucleotide and predicted ammo acid sequence of the protochordean pre-procionin pepttde. The consensus poly(A)’ addition site. AATAAA, 
is underhned. 
serted at ambiguous codon positions. The development 
of methods for the rapid amplification of 3’ and 5’ cDNA 
ends, the RACE techniques [7,16], using single gene- 
specific oligonucleotide primers, prompted the use of a 
deoxyinosine-containing cionin-specific oligoprimer in 
an effort to clone the cionin cDNA. Based on the cionin 
amino acid sequence, a 36-oligomer was synthesized, 
containing deoxyinosines at six ambiguous codon posi- 
tions (Table I, Fig. 1). This deoxyinosine oligomer 
primer was used in amplification of the cionin cDNA 
3’ end and the PCR product was subesquently cloned 
and sequenced. 
Primed cDNA synthesis was performed with poly(A)’ 
RNA from both the gastrointestinal tract and neuronal 
ganglion, and the single-stranded cDNAs were sub- 
jected to DNA polymerase amplification with the 26- 
sense oligomer (Table I) and oligo(dT),, Not1 primer/ 
adaptor. The amplification resulted in a small - 170 bp 
product. The product was cleaved with Not1 and EcoRI 
and cloned into pGEMl1 zf( -) vector. This construct 
was used to transform competent DH5a cells. Ampi- 
cillin resistant colonies were selected at random and 
subsequently plasmid mini-preparations and restriction 
enzyme analysis were performed. Southern blot analysis 
with the 26-sense oligomer as probe revealed three pos- 
itive clones, named pCIII,,, pCIII,,, and pCIII,,, con- 
taining a PCR-amplified CCK-like sequence. pCIII,, 
and pCIII,, contain amplified cDNA synthesized from 
gastrointestinal mRNA, and pCIII,, contains amplified 
cDNA synthesized from ganglionic mRNA. 
Sequence analysis of the three partial cDNAs re- 
vealed that cionin mRNA is expressed in both the neu- 
ronal ganglion and the gastrointestinal tract. When the 
resulting recombinant plasmid DNAs were sequenced. 
all the positions for deoxyinosine were replaced by de- 
oxyguanosine (G), indicating that the Tug polymerase 
selected deoxycytidine to pair with deoxyinosin (Fig. 1). 
62 
3.2. AmpliJication and cloning of the cionirz cDNA 3’ end 
bjl the inverse PCR technique 
The inverse polymerase chain reaction (IPCR) has 
been used to amplify low-abundance sequences, i.e. the 
human deoxycytidine kinase (dC Kinase) mRNA [9]. 
The cloning and subsequent sequence analysis of the 
partial cionin cDNAs. obtained by the IPPC technique 
(see above) allowed us to design a set of 3’ end-specific 
cionin PCR oligoprimers (Table I, #4 and #7). cDNA 
from the gastrointestinal tract was circularized using T4 
DNA and T4 RNA ligase as described [9]. and cDNA 
was used in 100 ~1 reactions with oligoprimers #4 and 
#7 (Table I) in order to amplify the cDNA derived from 
the gastrointestinal tract mRNA. Amplified PCR prod- 
A+ A- N 
,7,4 kb 
- 1.0 
_ 0.6 
c_ 0.4 
AIL3 
Fig. 3. Northern blot analysis of poly(A)’ and poly(A)- RNA, isolated 
from the gastrointestmal tract of Cio~rr ~ntrstmrrlrs. The Hybond-N 
membrane was subsequently hybridized with a [“PIUTP-1abelled 
cionm cRNA probe, derived from the DNA template, pCII1,. M 
Indicates the positions of RNA size markers. 
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INTESTINAL TRACT 
Glycme-extended 
NEURAL GANGLION 
ELUTION CONSTANT 
Wd) 
Fig. 4. Gel chromatography of extracts from the gastrointestinal tract (left) and the neural ganglion (right) of Ciorza intestznul~s. 1ml of the extracts 
was applied to calibrated Sephadex G50 superfine columns (10 x 1,000 mm). eluted at 4°C wtth 0.125 M NH,HCO, at a Row rate of 3.6 ml per 
h. Fracttons of 1.2 ml were collected and analysed by spectfic radiotmmunoassays. 
ucts were subsequently cloned into the EcoRI and 
BurnHl site of plasmid pGEM-3. 
3.3. Structural features of cionin cDNA and prepro- 
cionin 
One cDNA clone from the gastrointestinal tract, des- 
ignated p3/Cio-21, was sequenced to completion on 
both strands and found to contain a sequence of 510 bp 
(Fig. 2). A hexanucleotide sequence, AATAAA 
(poly(A) addition signal), was found 15 nucleotides up- 
stream from the poly(A)’ tail. Northern blot analysis 
confirmed the expression of a -500 nucleotide cionin 
mRNA in the gastrointestinal tract (Fig. 3). Moreover, 
IPCR cloning confirmed the established DNA se- 
quences from clones pCII1, and pCII1, as obtained by 
the IPPC technique (see section 2). PCR amplification 
of neuronal ganglion cDNA, using gene-specific prim- 
Cionin 
CCK 
Gastrin 
Met Asp Arg Asn Tyr Tyr 
Ser - - Asp - Met 
Glu Glu Glu Glu Ala - 
Cionin Ala Ile Glu Asp Val 
CCK Ser - 
Gastrin - - 
ers #4 and #9 in a first round, and #4 and #lO (Table 
I) in a second round PCR amplification, respectively, 
revealed that cionin mRNA is expressed in intestinal, as 
well as in ganglionic, tissue. 
The deduced preprocionin has 128 amino acids resi- 
dues and the 484 bp coding sequence begins with 
AGCmG, which is in agreement with the consensus 
sequence for translation initiation sites in eukaryotic 
cells [17]. The signal peptide of 20 amino acid residues 
is similar in size to those of preproCCK and preprogas- 
trin. The structure of procionin does not resemble that 
of the procaeruleins, having only one copy of cionin per 
propeptide. Instead, the overall sequence of procionin 
is also similar to that of proCCK in terms of C-terminal 
position of cionin in the propeptide between a single 
basic residue, Arg, and a classic amidation site, Gly- 
Lys-Arg. 
Glu Glu Asp Gln Tyr Asn 
Fig. 5. Compartson of the C-terminal parts of prociomn, rat proCCK. and rat progastrin. Gaps (blank spaces) are introduced to maximize homology 
between the sequences. Dashes indicate Identity between the sequences. Gly is the amide donor for the mature peptides. 
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3.4. E.ypression and processing oj‘procionin 
In view of the similarity of procionin with proCCK 
as well as the dual occurrence of cionin mRNA in the 
neural ganglion and intestinal tract, a corresponding 
dual occurrence of procionin and its products was also 
examined. Extracts of the neural ganglion contained 
only the cionin octapeptide amide without traces of 
precursors or processing intermediates. In contrast, the 
gastrointestinal extracts also contained significant con- 
centrations of glycine-extended cionin (Fig. 4). More- 
over, antibody G160, which is specific for tyrosyl- 
sulfated CCK-like peptides (such as the sulfated neu- 
ronal cionin), did not recognize the gastrointestinal 
cionin peptide (Fig. 4). Thus, in gastrointestinal cionin, 
the tyrosine in position seven is not sulfated. Hence, the 
neuronal processing of procionin is more complete than 
that of gastrointestinal cells. 
In addition to identification of the primary structure 
of preprocionin the present study has answered three 
questions raised by the original identification of cionin. 
First, procionin resembles mammalian proCCK more 
than progastrin. Accordingly, procionin displays only 
slight similarity with the procaeruleins [4]. Second, the 
pentapeptide sequence of procionin immediately N-ter- 
minal to the two O-sulfated tyrosyl residues in the 
cionin sequence contains two Arg and only one Asp 
(Fig. 2). Hence. the procionin sequence challenges the 
proposed consensus rules for tyrosyl 0-sulfation [5], 
and suggests a different substrate specificity of proto- 
chordean tyrosyl-protein sulfotransferase. Third, cionin 
mRNA and peptides are present also in the Cionu gut, 
although intestinal procionin is less processed than the 
neuronal procionin (Fig. 4). Thus, also with respect to 
tissue-specific expression and processing, the cionin sys- 
tem resembles the mammalian CCK system. 
Cionin was originally identified in extracts from the 
neuronal ganglion [3]. The finding of a gastrin/CCK- 
like peptide in this ganglion is in accordance with earlier 
immunochemical studies [ 14,18,19]. Interestingly, 
Thorndyke and Dockray 1191, using antibodies raised 
against mammalian gastrin-I 7. could not confirm an 
earlier observation of gastrin immunoreactivity in gut 
cells [20]. Since cionin reacts with C-terminal-directed 
gastrin antibodies, the intestinal immunoreactivity is 
presumably due to cionin. Our study supports such a 
contention, as PCR amplification of a cionin mRNA 
isolated from the gut confirmed the expression of cionin 
mRNA in the gut. Moreover, cionin peptides were also 
identified in gut tissue (Fig. 4). 
The procionin structure shows other remarkable fea- 
tures. Procionin contains mono- and dibasic processing 
sites similar to those of proCCK and progastrin 
([1.21,22], and Fig. 2). Moreover, alignment of the C- 
terminal sequences of procionin, proCCK, and progas- 
trin shows that procionin is more closely related to 
proCCK than to progastrin (Fig. 5). In known progas- 
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trin and proCCKs, the C-terminal amidation site, Gly- 
Arg-Arg, is followed by the tripeptide Ser-Ala-Glu. It 
has been proposed that phosphorylation of the Ser adja- 
cent to the amidation site is of regulatory significance 
[23]. However, the procionin amidation site Gly-Lys- 
Arg is followed by the tripeptide Ala-Ile-Glu rather 
than Ser-Ala-Glu (Fig. 5, lower panel). This indicates 
that processing at the procionin amidation site does not 
require phosphorylation. 
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